Genomind’s leading mental health test assesses your genes to help your clinician make smarter, more personalized treatment decisions regarding mental health medications. 87% of patients who have used Genomind® services have seen clinically measurable results.
The Myriad myRisk® Hereditary Cancer test is a 35-gene panel that identifies an elevated risk for eight hereditary cancers. MyRisk blends genetic testing status AND personal/family cancer history into clinically actionable risk assessment and follow-up